Iranian Red Crescent Medical Journal

Published by: Kowsar

Effect of Nepeta bracteata Benth. on Chronic Obstructive Pulmonary Disease: A Triple-Blinded, Randomized Clinical Trial

Ali Abdolahinia 1 , Mohsen Naseri 2 , * , Alireza Eslaminejad 3 , Farzaneh Ghaffari 4 and Aliakbar Velayati 5
Authors Information
1 Department of Iranian Traditional Medicine, Faculty of Medicine, Shahed University, Tehran, Iran
2 Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran
3 Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: December 2018, 20 (12); e80112
  • Published Online: December 1, 2018
  • Article Type: Research Article
  • Received: June 2, 2018
  • Revised: October 16, 2018
  • Accepted: October 27, 2018
  • DOI: 10.5812/ircmj.80112

To Cite: Abdolahinia A, Naseri M, Eslaminejad A, Ghaffari F, Velayati A. Effect of Nepeta bracteata Benth. on Chronic Obstructive Pulmonary Disease: A Triple-Blinded, Randomized Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(12):e80112. doi: 10.5812/ircmj.80112.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007;370(9589):741-50. doi: 10.1016/S0140-6736(07)61377-4. [PubMed: 17765523].
  • 2. Celli BR, MacNee W, Ats Ers Task Force . Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-46. doi: 10.1183/09031936.04.00014304. [PubMed: 15219010].
  • 3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet. 1997;349(9063):1436-42. doi: 10.1016/S0140-6736(96)07495-8. [PubMed: 9164317].
  • 4. MacNee W. Accelerated lung aging: A novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans. 2009;37(Pt 4):819-23. doi: 10.1042/BST0370819. [PubMed: 19614601].
  • 5. Hong M, Hong C, Chen H, Ke G, Huang J, Huang X, et al. Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2018;97(39). e12461. doi: 10.1097/MD.0000000000012461. [PubMed: 30278529]. [PubMed Central: PMC6181551].
  • 6. Bayan L, Modarres Mousavi SM, Gorji A. History of neurological disorders in persian medicine. J Res Hist Med. 2013;2(4 Nov).
  • 7. Abdolahinia A, Naseri M, Eslaminejad A, Ghaffari F, Velayati AA. Breathlessness from the perspective of the Persian medicine. Tanaffos. 2016;15(4):191-6. [PubMed: 28469674]. [PubMed Central: PMC5410114].
  • 8. Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. Curr Drug Targets. 2011;12(11):1595-653. doi: 10.2174/138945011798109464. [PubMed: 21561421]. [PubMed Central: PMC3170500].
  • 9. Abolhassani H, Naseri M, Mahmoudzadeh S. A survey of complementary and alternative medicine in Iran. Chin J Integr Med. 2012;18(6):409-16. doi: 10.1007/s11655-012-1124-9. [PubMed: 22821654].
  • 10. Asadbeigi M, Mohammadi T, Rafieian-Kopaei M, Saki K, Bahmani M, Delfan M. Traditional effects of medicinal plants in the treatment of respiratory diseases and disorders: An ethnobotanical study in the Urmia. Asian Pac J Trop Med. 2014;7S1:S364-8. doi: 10.1016/S1995-7645(14)60259-5. [PubMed: 25312151].
  • 11. Nejatbakhsh F, Karegar-Borzi H, Amin G, Eslaminejad A, Hosseini M, Bozorgi M, et al. Squill Oxymel, a traditional formulation from Drimia Maritima (L.) Stearn, as an add-on treatment in patients with moderate to severe persistent asthma: A pilot, triple-blind, randomized clinical trial. J Ethnopharmacol. 2017;196:186-92. doi: 10.1016/j.jep.2016.12.032. [PubMed: 27998692].
  • 12. Avicenna. Qanun fi al Tib [Canon of Medicine]. Beiruot: Alaalami Library; 2005.
  • 13. Fazly Bazzaz BS, Haririzadeh G, Imami SA, Rashed MH. Survey of Iranian plants for alkaloids, flavonoids, saponins, and tannins [Khorasan Province]. Int J Pharmacogn. 1997;35(1):17-30. doi: 10.1076/phbi.35.1.17.13275.
  • 14. Ghahraman A, Heydari J, Atar F, Hamzehei B. A floristic study of the southwestern slopes of Binaloud elevations (Iran: Khorassan Province). J Univ Sci Tehran. 2006;32(1):1-12.
  • 15. Bazzaz BS, Haririzadeh G. Screening of Iranian plants for antimicrobial activity. Pharm Biol. 2003;41(8):573-83. doi: 10.1080/13880200390501488.
  • 16. Siddiqui N, Rauf A, Latif A, Mahmood Z. Spectrophotometric determination of the total phenolic content, spectral and fluorescence study of the herbal Unani drug Gul-e-Zoofa (Nepeta bracteata Benth). J Taibah Univ Med Sci. 2017;12(4):360-3. doi: 10.1016/j.jtumed.2016.11.006.
  • 17. Wang J, Li FS, Pang NN, Tian G, Jiang M, Zhang HP, et al. Inhibition of asthma in OVA sensitized mice model by a traditional uygur herb Nepeta bracteata benth. Evid Based Complement Alternat Med. 2016;2016:5769897. doi: 10.1155/2016/5769897. [PubMed: 27073403]. [PubMed Central: PMC4814678].
  • 18. Hajiheydari MR, Yarmohammadi ME, Izadi P, Jafari F, Emadi F, Emaratkar E, et al. Effect of Nepeta bracteata Benth. on allergic rhinitis symptoms: A randomized double-blind clinical trial. J Res Med Sci. 2017;22:128. doi: 10.4103/jrms.JRMS_316_17. [PubMed: 29259639]. [PubMed Central: PMC5721487].
  • 19. Inui N, Matsushima S, Kato S, Yasui H, Kono M, Fujisawa T, et al. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1139-46. doi: 10.2147/COPD.S87058. [PubMed: 26124653]. [PubMed Central: PMC4476438].
  • 20. Liao YN, Hu WL, Chen HJ, Hung YC. The use of Chinese herbal medicine in the treatment of chronic obstructive pulmonary disease (COPD). Am J Chin Med. 2017;45(2):225-38. doi: 10.1142/S0192415X17500148. [PubMed: 28231744].
  • 21. Mirsadraee M, Khashkhashi Moghaddam S, Saeedi P, Ghaffari S. Effect of borago officinalis extract on moderate persistent asthma: A phase two randomized, double blind, placebo-controlled clinical trial. Tanaffos. 2016;15(3):168-74. [PubMed: 28210282]. [PubMed Central: PMC5304961].
  • 22. Almadana V, Sanchez J, Gómez-Bastero A, Valido A, Pavón M, Montemayor T. COPD assessment test (CAT) in the evaluation of COPD. Eur Respir J. 2012;40(Suppl 56).
  • 23. Barley EA, Jones PW. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. Eur Respir J. 1999;14(3):591-6. doi: 10.1034/j.1399-3003.1999.14c18.x. [PubMed: 10543280].
  • 24. Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12:20. doi: 10.1186/1471-2466-12-20. [PubMed: 22607459]. [PubMed Central: PMC3431277].
  • 25. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648-54. doi: 10.1183/09031936.00102509. [PubMed: 19720809].
  • 26. Fakharian A, Talischi F, Fallah Tafti S. Evaluation of the validity and reliability of the CAT (COPD assessment test) questionnaire among COPD patients attending Masih Daneshvari Hospital. Eur Respir J. 2015;46:PA725. doi: 10.1183/13993003.congress-2015.PA725.
  • 27. Kew KM, Dias S, Cates CJ. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: A network meta-analysis. Cochrane Database Syst Rev. 2014;(3). CD010844. doi: 10.1002/14651858.CD010844.pub2. [PubMed: 24671923].
  • 28. Kerwin EM, Kalberg CJ, Galkin DV, Zhu CQ, Church A, Riley JH, et al. Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: A randomized, parallel-group, 12-week study. Int J Chron Obstruct Pulmon Dis. 2017;12:745-55. doi: 10.2147/COPD.S119032. [PubMed: 28280319]. [PubMed Central: PMC5338844].
  • 29. Cheng SL, Su KC, Wang HC, Perng DW, Yang PC. Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: A prospective and randomized study focusing on clinical efficacy and the risk of pneumonia. Drug Des Devel Ther. 2014;8:601-7. doi: 10.2147/DDDT.S63100. [PubMed: 24920884]. [PubMed Central: PMC4044992].
  • 30. Asai K, Kobayashi A, Makihara Y, Johnson M. Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:803-11. doi: 10.2147/COPD.S79842. [PubMed: 25945045]. [PubMed Central: PMC4407765].
  • 31. Sarac P, Sayiner A. Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease. Tuberk Toraks. 2016;64(2):112-8. doi: 10.5578/tt.10778. [PubMed: 27481077].
  • 32. LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, et al. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study. Int J Chron Obstruct Pulmon Dis. 2016;11:1233-43. doi: 10.2147/COPD.S100445. [PubMed: 27354782]. [PubMed Central: PMC4907493].
  • 33. Feldman G, Maltais F, Khindri S, Vahdati-Bolouri M, Church A, Fahy WA, et al. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 mug compared with tiotropium 18 mug in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:719-30. doi: 10.2147/COPD.S102494. [PubMed: 27103795]. [PubMed Central: PMC4827908].
  • 34. Mukaida K, Hattori N, Kondo K, Morita N, Murakami I, Haruta Y, et al. A pilot study of the multiherb Kampo medicine bakumondoto for cough in patients with chronic obstructive pulmonary disease. Phytomedicine. 2011;18(8-9):625-9. doi: 10.1016/j.phymed.2010.11.006. [PubMed: 21177084].
  • 35. Liu M, Zheng F, Ni L, Sun Y, Wu R, Zhang T, et al. Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study. J Tradit Chin Med. 2016;36(4):418-26. doi: 10.1016/S0254-6272(16)30057-7. [PubMed: 28459236].
  • 36. Chen Y, Shergis JL, Wu L, Yu X, Zeng Q, Xu Y, et al. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease. Complement Ther Med. 2016;29:94-108. doi: 10.1016/j.ctim.2016.09.017. [PubMed: 27912964].
  • 37. Mokaberinejad R, Zafarghandi N, Bioos S, Dabaghian FH, Naseri M, Kamalinejad M, et al. Mentha longifolia syrup in secondary amenorrhea: A double-blind, placebo-controlled, randomized trials. Daru. 2012;20(1):97. doi: 10.1186/2008-2231-20-97. [PubMed: 23351184]. [PubMed Central: PMC3556020].
  • 38. Mozaffarpur SA, Naseri M, Esmaeilidooki MR, Kamalinejad M, Bijani A. The effect of cassia fistula emulsion on pediatric functional constipation in comparison with mineral oil: A randomized, clinical trial. Daru. 2012;20(1):83. doi: 10.1186/2008-2231-20-83. [PubMed: 23351337]. [PubMed Central: PMC3556012].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments